Stroke rehabilitation at Midland

Our research team has a focus on engagement with key stakeholders for improving patient outcomes collaborating with The Florey Institute of Neuroscience and Mental Health as well as Australian hospitals and universities. The research activities range from randomised controlled clinical trials through to observational and audit studies. The importance of translational research is evident in our contribution and collaboration to specific clinical patient registries and Biobank for Inherited Disorders of Lipid Metabolism.

Rehabilitation can greatly improve a patient’s quality of life after a stroke. The research that we conduct at the St John of God Midland Private and Public Hospital aims to develop models of care that will ultimately help patients get their independence back and prepare them for life when they return home.

The areas of research that we focus on include:

• Using state-of-the-art technology, developing a model of care that will enable us to predict the motor outcomes of stroke patients.
• A research study investigating the provision of the highest quality occupational therapy care to stroke patients.
• Trial of Exenatide in Acute Ischaemic stroke.

Dr Tim Bates, Consultant - Gen Med & Med Specialties
Dr Patrick Salvaris, General Physician & Stroke Physician
Lynda Southwell, Research Nurse
Rhianna Ingleton, Senior Occupational Therapist
Tiing Lio, Senior Physiotherapist

St John of God Midland Public and Private Hospitals

AFFINITY Trial Collaboration. (2020). Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trial. Lancet Neurology, 19, 651-660.Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trial - The Lancet Neurology

Bates, T., Phatourous, C., & Van Heedren, J. (2017) Spot sign, prognosis and intracerebral haemorrhage: case study. QJM: An international journal of medicine. 110 (1):51-52.
Spot sign, prognosis and intracerebral haemorrhage (researchgate.net)

Chan, D., Pang, J., Hooper, J., Bell, A., Bates, T., Burnett, R., & Watts, F. (2018) A comparative analysis of phenotypic predictors of mutations in familial hypercholesterolemia. The Journal of Clinical Endocrinology and Metabolism, 103(4), 1704-1714.A Comparative Analysis of Phenotypic Predictors of Mutations in Familial Hypercholesterolemia - PubMed (nih.gov)

Kho, L.K., Bates, T.R., Thompson, A., Dharsono, F., Prentice, D. (2019) Cerebral embolism and carotid-hyoid impingement syndrome. Journal of Clinical Neuroscience. 64:27-29 Cerebral embolism and carotid-hyoid impingement syndrome - PubMed (nih.gov)

Pang, J., Martin, C., Bates, T., Hooper, J., Bell, A., Burnett, R., Norman, R. & Watts, F. (2018) Parent-child genetic testing for familial hypercholesterolemia in an Australian context. Journal of Pediatrics and Child Health. 54(7): 741-747. doi.org/10.1111/jpc.13898

Pang, J., Abraham, A., Bates, T., Bell, D., Hooper, J., Burnett, J., & Watts, G. F. (2017) Predictors of subclinical coronary artery disease in asymptomatic patients with familial hypercholesterolemia. Atherosclerosis 263, p. E228-E228. doi.org/10.1016/j.atherosclerosis.2017.06.743

Pang, J., Abraham, A., Vargas-García, C., Bates, T.R., Chan, D.C., Hooper, A.J., Bell, D.A., Burnett, J.R., Schultz, C.J., Watts, G.F. An age-matched computed tomography angiographic study of coronary atherosclerotic plaques in patients with familial hypercholesterolaemia. Atherosclerosis. 2020;298:52-57. An age-matched computed tomography angiographic study of coronary atherosclerotic plaques in patients with familial hypercholesterolaemia - PubMed (nih.gov)